CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for SL Science Holding Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

SL Science Holding Ltd
11F,
No. 479 Chongyang Road, Nangang District
Phone: +886 226516826p:+886 226516826 TAIPEI, 115  Taiwan Ticker: SLBTSLBT
Business Summary
SL Science Holding Ltd is a Taiwan-based company mainly engaged in the research and development (R&D) of cell and gene therapies for cancer treatment and regenerative medicine. The Company develops investigational immune cell technologies, including gamma delta (?d) T cells, Armed-T cells and exosome-based formulations, and operates through its biotechnology and oncology research activities.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/202612/31/2025YesYes---

Industries
SIC Code Description
2836 Biological products, except diagnostic substances
6770 Blank checks
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, Chief Executive Officer MingyuLi 42 7/1/2024 7/1/2024
Chief Financial Officer MinZhai 54 7/1/2024 7/1/2024
Independent Director TianchenCai 52 11/1/2024 11/1/2024
Independent Director JiayuanTong 52 11/1/2024 11/1/2024
Independent Director QianXu 44 11/1/2024 11/1/2024

Business Names
Business Name
Horizon Space Acquisition II Corp.
HSPT
HSPTU
SL BIO Ltd.
SLBT

General Information
Outstanding Shares: 560,759,757 (As of 6/18/2026)
Shareholders: 7
Stock Exchange: NASD


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, June 22, 2026